Share Name Share Symbol Market Type Share ISIN Share Description
Woodford Patient Capital Trust LSE:WPCT London Ordinary Share GB00BVG1CF25 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.80p +1.01% 80.20p 955,869 16:35:02
Bid Price Offer Price High Price Low Price Open Price
80.00p 80.30p 80.00p 78.80p 79.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments -3.44 -0.42 663.3

Woodford Patient Capital (WPCT) Latest News (1)

More Woodford Patient Capital News
Woodford Patient Capital Takeover Rumours

Woodford Patient Capital (WPCT) Share Charts

1 Year Woodford Patient Capital Chart

1 Year Woodford Patient Capital Chart

1 Month Woodford Patient Capital Chart

1 Month Woodford Patient Capital Chart

Intraday Woodford Patient Capital Chart

Intraday Woodford Patient Capital Chart

Woodford Patient Capital (WPCT) Discussions and Chat

Woodford Patient Capital Forums and Chat

Date Time Title Posts
20/8/201823:50::: WOODFORD PATIENT CAPITAL TRUST :::4,163
22/6/201817:47Woodford Patient Capital Trust198

Add a New Thread

Woodford Patient Capital (WPCT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-08-20 15:52:1978.802,3651,863.62O
2018-08-20 15:35:0280.202318.45UT
2018-08-20 15:27:5480.201,246999.23O
2018-08-20 15:22:1880.209,3527,499.84O
2018-08-20 15:12:4780.201,3001,042.54O
View all Woodford Patient Capital trades in real-time

Woodford Patient Capital (WPCT) Top Chat Posts

Woodford Patient Capital Daily Update: Woodford Patient Capital Trust is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker WPCT. The last closing price for Woodford Patient Capital was 79.40p.
Woodford Patient Capital Trust has a 4 week average price of 77.80p and a 12 week average price of 72.90p.
The 1 year high share price is 100.20p while the 1 year low share price is currently 70.50p.
There are currently 827,000,000 shares in issue and the average daily traded volume is 1,427,880 shares. The market capitalisation of Woodford Patient Capital Trust is £663,254,000.
ltcm1: I think a more straightforward way of looking at it is that Woodford has lost 170m odd of cash to date in this fund. That is before we address the question of so much of WPCT being in illiquid and hard to sell assets. As for the Sensyne Health AIM, one of the Woodford elite posted over a week ago in response to my asking why WPCT was going up - 'I know and I'm not telling.' So now we all know and the majority of the uplift will be baked into the WPCT price, offsetting heavy recent falls in ALM, EVE, XSG and the old favourite RM2, which is currently trading 20% below the price Woodford rescued it at.
daffyjones: colonic - it might be difficult for you to process basic information, but it hardly takes a supercomputer to figure out the proportion of WPCT that PRTA comprised previously. Just look at the 2016 annual report - PRTA made up 14.34% of WPCT. And if you look at some of the news reports from 2017 (google "Woodford: Prothena conviction as strong as ever" from November 2017) you'll see that percentage had risen to over 15%. A huge amount to bet on a single company, and a bet that didn't pay off. Woodford hasn't sold any shares in PRTA. The reason why Prothena is now only 3.23% of the WPCT portfolio is that share price has collapsed by so much. Another Woodford failure. ___ July's monthly roundup now out on Woody's website. Curious lack of any references to EVE, Drax or any of the other recent shenanigans. Lots of macro stuff about how China's economy is set up for a big fall, which I agree with, but how is that relevant to any of Woodford's funds?
ltcm1: The meandering WPCT price today looks more funkified than a Kool and the Gang gig! Could it be the price is being nudged higher in scant lunchtime trading because the forces of Woodward are aware a leading analyst has this morning published two unfavourable notes on the Woodford empire??? Certainly there is the look of false narrative on the 1200 to 1300 price volume action. You would think when the news filters through we will see a correction and position adjustments, ie selling to you and me.
chucko1: ltcm1, at least as of May 11th, there had been no sales in any of his three funds holding the stock (I am now back at my desk so I can look these things up). This is why I was trying to recall what the previous holding(s) had been. For example, at some stage, the share price was 500p ad it is now 375p, so a 25% reduction. All other things being equal (i.e the prices of all other holdings in aggregate) this would imply a percentage fund holding reduction to: (assume original holding was 9.00% and fund price is 100p (arbitrary)) 9% x 100 x (1 - SPR%) / (100 x (1 - SPR%)) where SPR% is the Share Price Reduction (%) of PURP and I assume an original holding of 9% So, using SPR% of 25%, we get a new holding of 6.92%. And this is wiothout selling a single share. All theoretical of course, as it all depends on what timeframe we are investigating. But it illustrates the point.
daffyjones: Why did you sell on the next working day, when the share price was still massively below the launch price? Surely if Woody is such a biotech genius, you'd expect the share price to rise further at least to get back where it started at 100p. Why did you turn your back on this guaranteed future profit? Could it be that you don't actually have faith in the long term prospects of this Patient Capital Trust? Thanks for joining us bears! Glad you saw reason in the end.
saltraider: Hands up ... I am really not a 'harsh' sort of a person. Apologies to @orinocor for being excessively terse. The trouble is that there are a fair few people around and about who are trying to manipulate the WPCT share price ... and using some pretty dubious means to do it. They are shorting WPCT and trying to use other 'communications' avenues to add to the pressure on the price at the same time. That includes pushing blatantly fake news. When you step in (@orinocor) and make negative statements based on apparently zero knowledge of the basic WPCT concept, you are just accidentally (and ignorantly ... sorry!) aiding and abetting the manipulators.
daffyjones: Andyj: "Having bought at 74p, I was not expecting such a quick return of 14% in a matter of weeks" IQ51: "I bought WPCT shares just after 8.00 a.m. on February 6 2018. They cost me 73p each." Mazarin: "I bought when it was much less." Mochyn: "I and the other more intelligent guys here are sitting on at least a 16% rise" Wow!!! Got to love how all the WPCT rampers suddenly claim to have bought in at 73-74p, right at the very bottom. Who knew we had so many expert falling-knife catchers here?! They all managed to time their purchases perfectly right at the trough of the share price. But for some reason they were in this thread for months beforehand ramping WPCT at 90p and 95p and 100p, without apparently actually having made any purchases at that price. How curious! TROLL-FIB ALERT!!!
daffyjones: Really bizarre how all the WPCT rampers have come out of the woodwork to gloat about a 9% rise in the share price. The shares are still 17% below their launch price. WPCT will need to rise by 45% from its current level in order to meet its cumulative hurdle for Woody to receive a fee. By any reckoning, WPCT is still far underperforming against expectations and against the general market. Yes it's nice that the share price has risen to 83.4p but don't overdo the celebrations. Don't worry, when it gets back to 100p I'll be the first to congratulate you all on finally breaking even.
daffyjones: Some positive press coverage at last for Woody! To be fair he was started from a terrible position in Feb. [Begins:] An unexpected recovery for Woodford Patient Capital Trust has made the struggling investment trust the surprise top performer among the sector specialist funds in March, albeit amid a substantial slump for the wider biotech and pharmaceuticals sector. WPCT was the top performer out of the 13 closed end funds investing in wholly or largely in biotech or healthcare, in terms of both NAV and share price performance, in March, and was a mid-range performer over the first quarter. This contrasts markedly with its poor longer term performance for NAV and share price in absolute terms and in comparison with benchmarks and peers. WPCT achieved a 0.6% rise in NAV and a 6.7% increase in share price in the month, which compared with negative 1-5% changes in NAV for all the other funds and 1.5-6.5% declines in price, for all but one other fund.
dr biotech: I am pretty sure that he has all his money invested in either the WPCT or his equity funds. He is doing a live webcast as I type. NEIL WOODFORD says: Today 2:00 pm Kelvin (and others that have asked similar questions), The weakness of the WPCT share price and NAV since the start of 2016 has been the product of the pretty severe sell-off in shares across healthcare, biotech and early-stage quoted stocks, both here in the UK and in the US. Much of this, we believe to be driven by short-term positioning and rotational activity amongst the fund management community. We don’t believe that it is driven by a correction of over-valuation, nor by a deterioration in fundamentals. We remain very pleased with the underlying progress of the businesses in which we have invested in the trust. Indeed, in what has been a pretty short space of time since launch, our expectations for the underlying performance of many businesses in the portfolio have been exceeded. This is a long-term vehicle. We hope to deliver good performance in the short-term but believe we should be judged over the 3 to 5 year time scale we have talked about consistently since launch. Kind regards Neil
Woodford Patient Capital share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180821 02:38:45